查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1881663

結構性心臟病器材市場－全球產業規模、佔有率、趨勢、機會和預測，按類型（SAVR、TAVR、二尖​​瓣修復、左心耳封堵術）、地區和競爭格局分類，2020-2030年預測

Structural Heart Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (SAVR, TAVR, Mitral Repair, LAAC ), By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球結構性心臟器材市場規模為72億美元，預計2030年將以9.11%的複合年成長率成長至121.5億美元。結構性心臟器械包括用於治療心臟瓣膜、心腔或主要動脈解剖缺陷或疾病的醫療植入物和系統，通常透過微創手術進行。結構性心臟病在全球日益普遍，尤其是在老化人口中，是推動市場成長的主要因素。微創介入治療（例如經導管主動脈瓣置換術）的日益普及，以及技術的不斷進步，進一步促進了市場擴張，因為這些技術能夠縮短恢復時間並改善患者預後。

市場概覽
預測期 2026-2030
2024年市場規模 72億美元
2030年市場規模 121.5億美元
2025-2030年複合年成長率 9.11%
成長最快的細分市場 經導管主動脈瓣置換術 (TAVR)
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

介入性影像和人工智慧引導導航技術的進步

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球結構性心臟病器材市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依類型（SAVR（外科主動脈瓣置換術）、TAVR（經導管主動脈瓣置換術）、二尖瓣修補術（瓣環成形術）、LAAC（左心耳封堵術））
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美結構性心臟病器材市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲結構性心臟病器材市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區結構性心臟病器材市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲結構性心臟病器材市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲結構性心臟病器材市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球結構性心臟器材市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Abbott Laboratories, Inc.
  • Edwards Lifesciences Corporation
  • Medtronic Plc
  • Boston Scientific Corporation
  • Lepu Medical Technology Holding Company
  • TTK Healthcare Limited
  • Biomerics, LLC
  • Braile Biomedic
  • Artivion, Inc.
  • JenaValve Technology Inc

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 21764

The Global Structural Heart Devices Market, valued at USD 7.20 Billion in 2024, is projected to experience a CAGR of 9.11% to reach USD 12.15 Billion by 2030. Structural heart devices comprise medical implants and systems addressing anatomical defects or disorders of the heart's valves, chambers, or major arteries, typically via minimally invasive procedures. Market growth is fueled by the escalating global prevalence of structural heart diseases, particularly in the aging population. The increasing adoption of minimally invasive interventions, such as Transcatheter Aortic Valve Replacement, offering reduced recovery times and improved patient outcomes, further propels market expansion, alongside ongoing technological advancements.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 7.20 Billion
Market Size 2030USD 12.15 Billion
CAGR 2025-20309.11%
Fastest Growing SegmentTAVR (Transcatheter Aortic Valve Replacement)
Largest MarketNorth America

Key Market Drivers

The rising prevalence of structural heart diseases represents a fundamental driver for the global structural heart devices market, creating a substantial and expanding patient demographic requiring advanced therapeutic interventions. Conditions such as valvular heart disease, cardiomyopathy, and congenital heart defects, which often necessitate mechanical correction or replacement, are increasingly being diagnosed due to improved awareness and diagnostic capabilities. This growing disease burden directly translates into a higher demand for innovative devices like transcatheter heart valves and annuloplasty rings. For instance, according to "The Global Burden of Valvular Heart Disease: From Clinical Epidemiology to Management", in March 2023, more than 4% of people over 75 years old were found to have a clinically relevant tricuspid regurgitation, highlighting the significant need for effective treatment solutions for various structural heart conditions beyond previously highlighted disorders.

Key Market Challenges

The substantial cost associated with advanced structural heart devices presents a significant impediment to the growth of the Global Structural Heart Devices Market. These high expenses directly impact healthcare budgets and reimbursement policies, particularly in health systems with constrained financial resources. This economic barrier can restrict the widespread adoption of innovative therapies, limiting access for a broader patient population across different economic regions.

Key Market Trends

Advancements in Interventional Imaging and AI-Guided Navigation

This trend underscores the evolving sophistication of imaging modalities and the integration of artificial intelligence in guiding structural heart interventions. These technological enhancements improve procedural precision and safety, ultimately contributing to favorable patient outcomes. AI-driven algorithms assist in real-time visualization, optimal device placement, and comprehensive pre-procedural planning, which can refine procedural pathways. For instance, according to the American College of Cardiology's Annual Scientific Session, in March 2025, patients whose evaluation was non-invasively guided by a novel, AI-powered technique underwent approximately 1% fewer procedures with comparable outcomes to those guided by ultrasound-based imaging.

Key Market Players

  • Abbott Laboratories, Inc.
  • Edwards Lifesciences Corporation
  • Medtronic Plc
  • Boston Scientific Corporation
  • Lepu Medical Technology Holding Company
  • TTK Healthcare Limited
  • Biomerics, LLC
  • Braile Biomedic
  • Artivion, Inc.
  • JenaValve Technology Inc

Report Scope:

In this report, the Global Structural Heart Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Structural Heart Devices Market, By Type:

  • SAVR (Surgical Aortic Valve Replacement)
  • TAVR (Transcatheter Aortic Valve Replacement)
  • Mitral Repair (Annuloplasty)
  • LAAC (Left Atrial Appendage Closure)

Structural Heart Devices Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Structural Heart Devices Market.

Available Customizations:

Global Structural Heart Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Structural Heart Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (SAVR (Surgical Aortic Valve Replacement), TAVR (Transcatheter Aortic Valve Replacement), Mitral Repair (Annuloplasty), LAAC (Left Atrial Appendage Closure))
    • 5.2.2. By Region
    • 5.2.3. By Company (2024)
  • 5.3. Market Map

6. North America Structural Heart Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Structural Heart Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
    • 6.3.2. Canada Structural Heart Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
    • 6.3.3. Mexico Structural Heart Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type

7. Europe Structural Heart Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Structural Heart Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
    • 7.3.2. France Structural Heart Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
    • 7.3.3. United Kingdom Structural Heart Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
    • 7.3.4. Italy Structural Heart Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
    • 7.3.5. Spain Structural Heart Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type

8. Asia Pacific Structural Heart Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Structural Heart Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
    • 8.3.2. India Structural Heart Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
    • 8.3.3. Japan Structural Heart Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
    • 8.3.4. South Korea Structural Heart Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
    • 8.3.5. Australia Structural Heart Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type

9. Middle East & Africa Structural Heart Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Structural Heart Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
    • 9.3.2. UAE Structural Heart Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
    • 9.3.3. South Africa Structural Heart Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type

10. South America Structural Heart Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Structural Heart Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
    • 10.3.2. Colombia Structural Heart Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
    • 10.3.3. Argentina Structural Heart Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Structural Heart Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott Laboratories, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Edwards Lifesciences Corporation
  • 15.3. Medtronic Plc
  • 15.4. Boston Scientific Corporation
  • 15.5. Lepu Medical Technology Holding Company
  • 15.6. TTK Healthcare Limited
  • 15.7. Biomerics, LLC
  • 15.8. Braile Biomedic
  • 15.9. Artivion, Inc.
  • 15.10. JenaValve Technology Inc

16. Strategic Recommendations

17. About Us & Disclaimer